The market for home healthcare involves broad range of the medical devices, which help the patients to diagnose or treat various chronic diseases. The home healthcare devices play a crucial role in providing the cost-effective healthcare treatments to patients. These devices provide beneficial business opportunities owing to the rising acceptance, technological advancements and cost-effective alternatives of these devices as compared to the other treatment modalities (hospital treatment). The Asia-Pacific home healthcare market is growing at a promising CAGR due to the increasing aging population and rising number of individuals diagnosed with the chronic illness such as cardiac disorders, diabetes and various respiratory diseases. In addition, the Asia-Pacific home healthcare devices are still at the nascent stage in developing regions such as India and witnessing the lucrative growth rate during the analysis period. These factors would fuel the requirements of home healthcare devices during the study period, and hence will boost the market growth. However, the high cost coupled with the reimbursement issues related with adoption of home healthcare devices would restrain the market growth.
Get the PDF brochure of this market study: https://www.alliedmarketresearch.com/request-toc-and-sample/1202
The Asia-Pacific home healthcare market is segmented on the basis of device types, end users and geography. Based on device types, the market is segmented into diagnostics and monitoring devices, mobility assist devices, therapeutic home healthcare devices and medical supplies. Based on the end users, the Asia-Pacific home healthcare market is categorized into pediatrics, geriatrics and others. Geographically, the Asia-Pacific home healthcare market is segmented into China, Japan, India, Australia and others. Emerging economies such as India, China, Singapore and Malaysia are the potential geographies for market expansion due to improving healthcare standards. These economies have a large presence of domestic manufacturers of home healthcare devices, which contribute to an increase in the market competition for multinational giants by adopting the strategy of price penetration.
Companies profiled in this report are Bayer AG, Cardinal Health, Inc., Abbott Laboratories, GE Healthcare, Gentiva Health Services, Inc., Johnson & Johnson Services, Inc., Invacare Corporation, 3M Health Care, Phillips Healthcare, F. Hoffmann-La Roche Ltd., Omron Healthcare, Inc. and Medtronic Inc.